-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OR1TEESbWtkh74wTeXrDoOI7y/QkHEd/bGf1kDIkYxNdNKfwHGQuDz2zt4sCSyTy OTD/aXGuqNzTsEOXxdEeKw== 0001209191-05-024491.txt : 20050506 0001209191-05-024491.hdr.sgml : 20050506 20050506174008 ACCESSION NUMBER: 0001209191-05-024491 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050506 FILED AS OF DATE: 20050506 DATE AS OF CHANGE: 20050506 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 1204 BUSINESS ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GIBSON NEIL CENTRAL INDEX KEY: 0001220036 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15190 FILM NUMBER: 05809253 MAIL ADDRESS: STREET 1: C/O OSI PHARMACEUTICALS INC STREET 2: 58 S SERVICE RD CITY: MELVILLE STATE: NY ZIP: 11747 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2005-05-06 0 0000729922 OSI PHARMACEUTICALS INC OSIP 0001220036 GIBSON NEIL C/O OSI PHARMACEUTICALS, INC. 58 SOUTH SERVICE ROAD, SUITE 110 MELVILLE NY 11747 0 1 0 0 Vice President Research Common Stock 2005-05-06 4 M 0 2500 21.55 A 5780 D Common Stock 2005-05-06 4 S 0 16 47.24 D 5764 D Common Stock 2005-05-06 4 S 0 100 47.27 D 5664 D Common Stock 2005-05-06 4 S 0 1381 47.28 D 4283 D Common Stock 2005-05-06 4 S 0 100 47.32 D 4183 D Common Stock 2005-05-06 4 S 0 100 47.42 D 4083 D Common Stock 2005-05-06 4 S 0 361 47.44 D 3722 D Common Stock 2005-05-06 4 S 0 442 47.46 D 3280 D Stock Option (Right to Buy) 21.55 2005-05-06 4 M 0 2500 0.00 D 2003-06-12 2012-06-11 Common Stock 2500 834 D One third of the stock option became exercisable one year after the date of the grant and the remainder vested ratably on a monthly basis over the succeeding 24 months. The stock option was granted pursuant to one of the Issuer's incentive and non-qualified stock option plans and is exempt under Rule 16b-3. Includes only options with the same termination date. Robert L. Van Nostrand by Power of Attorney 2005-05-06 -----END PRIVACY-ENHANCED MESSAGE-----